CDSCO Licence for HIV Test Kits in India

An HIV test kit detects antibodies or antigens to HIV, and the consequence of a wrong result — for the individual and, in blood screening, for a transfusion recipient — is severe. That is why CDSCO regulates HIV test kits as a Class C in-vitro diagnostic (IVD), one of the higher IVD tiers, with a rigorous performance-evaluation report behind the licence. This guide covers the full CDSCO pathway for HIV test kits under the Medical Devices Rules, 2017 — classification, licence route, the performance evidence, the documents, the fees and the timeline.

📋 Is a CDSCO Licence Mandatory for HIV Test Kits?

Yes. An HIV test kit is a notified in-vitro diagnostic and cannot be manufactured, imported or sold in India without a CDSCO licence. Because HIV detection is Class C, a domestic manufacturer applies to the Central Licensing Authority in Form MD-7 for a Form MD-9 licence, and an importer applies in Form MD-14 for a Form MD-15 import licence. In India, HIV-kit performance evaluation is carried out at designated referral laboratories.

🧭 Risk Classification of HIV Test Kits

Every medical device in India is placed in one of four risk classes under the First Schedule of the Medical Devices Rules, 2017. The class is the single most important decision in the whole application — it fixes which authority you file with, which form you use, the fee, the audit route and the timeline.

HIV Test Kits are classified as Class C. An IVD that detects an infectious agent (HIV) where an incorrect result poses a significant risk to the individual and to public/transfusion safety is classified at Class C under the IVD classification rules. Classification follows the CDSCO classification list for the relevant medical-device category read with the First Schedule rules; where a device could fall in two classes, the higher class applies, and an accessory is classified in its own right.

🪪 Which CDSCO Licence You Need for HIV Test Kits

There are two distinct routes, and which one applies depends on whether you make the device in India or bring it in from overseas:

• To manufacture hiv test kits in India (Class C) — apply in Form MD-7 to the Central Licensing Authority (CDSCO headquarters); the licence is granted in Form MD-9. A CDSCO joint audit team inspects the manufacturing site before the licence is granted — site inspection is mandatory for Class C and D.
• To import hiv test kits (any class) — the overseas manufacturer appoints an Indian Authorised Agent who holds a valid manufacturing or wholesale licence, and the agent files Form MD-14 with the Central Licensing Authority. The import licence is granted in Form MD-15 and names the manufacturer, each site and every device covered.
• To import a small quantity for testing, evaluation, demonstration or clinical investigation — a separate test licence is used: Form MD-12 application, Form MD-13 licence.
• Loan licence — a manufacturer using another licensee's approved premises applies in Form MD-4 (Class A/B) or Form MD-8 (Class C/D) for a loan licence in Form MD-6 or MD-10.

📘 Applicable Standards for HIV Test Kits

HIV test kits are evaluated principally on their performance evidence, supported by IVD quality and labelling standards:

• Performance Evaluation Report (PER) — analytical and clinical sensitivity and specificity against reference panels, at a CDSCO-designated evaluation laboratory.
• ISO 13485 — quality management system for the IVD manufacturer.
• ISO 23640 — stability evaluation of the IVD reagents (kit shelf-life).
• ISO 14971 — risk management, including false-negative/false-positive consequences.
• ISO 18113 — IVD labelling and information supplied by the manufacturer.
• WHO prequalification / reference-panel evidence where available, to support performance.

🗂️ The Core Technical Dossier — Required for Every Application

Whether you file for a manufacturing licence or an import licence, CDSCO expects the same backbone of technical evidence built around the device. Getting this base right is what decides whether the file clears in one review cycle or comes back as a deficiency letter; the device-specific documents in the next section sit on top of it.

• Covering letter and application form — Form MD-3 / MD-7 (manufacture) or Form MD-14 (import), completed on the CDSCO Medical Device Online (SUGAM) portal, stating every device, variant and site.
• Device Master File (DMF) — the heart of the dossier: device description and intended use, materials, design and manufacturing information, risk management (ISO 14971) file, verification and validation data, sterilisation validation where applicable, shelf-life and stability data, and the Essential Principles checklist.
• Plant Master File (PMF) — the site: layout, equipment, utilities, HVAC and water systems, organisation chart with the competent technical staff, and the quality-system procedures that govern production.
• ISO 13485 Quality Management System certificate — a current QMS certificate for the manufacturing site, with the scope covering the device.
• Essential Principles of Safety and Performance — a completed checklist mapping the device against each applicable essential principle, with the standard or evidence relied on for each.
• Risk management file — an ISO 14971 risk analysis identifying hazards, risk controls and residual-risk justification for the device.
• Test / performance reports — reports against the applicable BIS/IS or ISO/IEC standards for the device, from an accredited laboratory.
• Labels, Instructions for Use (IFU) and packaging — artwork that meets the labelling requirements of the Medical Devices Rules, including manufacturer, licence number, sterile status and single-use symbols where relevant.
• Undertaking and declaration — that the device conforms to the Essential Principles and the applicable standards, signed by the authorised signatory.
• Fee receipt — the government fee paid online through the CDSCO portal / Bharatkosh.

➕ Device-Specific Documents for HIV Test Kits

On top of the core dossier, an HIV-kit IVD file must carry the performance evidence CDSCO expects:

• Performance Evaluation Report from a CDSCO-designated referral laboratory — sensitivity, specificity and reproducibility.
• Reference-panel results including seroconversion panels where applicable.
• Stability (ISO 23640) data — kit shelf-life and transport stability.
• Cut-off determination and cross-reactivity evidence.
• Lot-to-lot consistency data.
• Country-of-origin approval / Free Sale Certificate for imports.

For an import licence (Form MD-14) there are three further essentials on top of the dossier above:

• Free Sale Certificate (FSC) — issued by the National Regulatory Authority of the country of origin, showing the device is freely sold there; not older than the period CDSCO accepts, and legalised (apostille or embassy attestation).
• Country-of-origin regulatory approval — e.g. US FDA 510(k)/PMA, EU CE certificate, or equivalent, evidencing marketing clearance in a reference market.
• Power of Attorney and Authorised Agent licence — a notarised, legalised Power of Attorney from the manufacturer to the Indian Authorised Agent, and the agent's valid wholesale or manufacturing licence.

🏭 QMS & Essential Principles — What CDSCO Checks

The Medical Devices Rules, 2017 are built on two pillars, and both are assessed for hiv test kits:

• Essential Principles of Safety and Performance (Fifth Schedule) — the device must be safe and perform as intended, with risks reduced as far as possible and acceptable against its benefit. Conformity is shown by meeting recognised standards and by the risk-management file.
• Quality Management System (ISO 13485) — design controls, purchasing and supplier control, process validation, traceability, complaint handling and CAPA must be in place and evidenced at audit.
• Risk management (ISO 14971) — a living file, not a one-off document; residual risks must be justified and communicated in the IFU.
• Clinical evidence — proportionate to the class: a clinical evaluation report drawing on literature and equivalence for lower-risk devices, and clinical investigation data for many Class C/D and novel devices.

🏷️ HIV Test Kits Label & IFU Requirements

IVD labelling (ISO 18113) is checked closely for lot, expiry and intended-use information:

• Product name, IVD symbol, the analyte (HIV-1/2, antigen/antibody) and intended use.
• Manufacturer name and address, and the CDSCO licence number.
• Lot/batch number, date of manufacture and expiry date.
• Storage conditions and specimen type.
• A clear statement on confirmatory testing and result interpretation in the IFU.

⚖️ Screening, Diagnostic or Self-Test, and the Referral-Lab Step

HIV kits differ by intended use — blood-donor screening, diagnostic testing and self-testing — and the intended use shapes the evidence and the exact class, so confirm it against the current CDSCO IVD list. What is common to HIV kits in India is the mandatory performance evaluation at a designated referral laboratory before the licence issues; you cannot self-certify performance. Build the referral-lab evaluation into your timeline from the start, because it is on the critical path.

🛠️ Step-by-Step Registration Process

1. Confirm the classificationFix the risk class against the CDSCO classification list and the First Schedule — this decides the form, the authority, the fee and the audit route before anything else is drafted.
2. Choose the routeManufacturing (Form MD-3 / MD-7) or import (Form MD-14). Importers appoint an Indian Authorised Agent holding a valid manufacturing or wholesale licence.
3. Build the Device Master File and Plant Master FileAssemble device description, materials, design and process data, ISO 14971 risk file, sterilisation and stability data, and the site file with the QMS.
4. Complete the Essential Principles checklistMap the device against each applicable essential principle and cite the BIS/IS or ISO/IEC standard or test report relied on for each.
5. Draw the test and performance reportsTest to the applicable standards at an accredited laboratory; sterile and measuring devices carry additional validation.
6. Register and file on the CDSCO Online (SUGAM) portalCreate the account, pay the government fee online and upload the full dossier under the correct form.
7. Site audit / inspectionNotified-Body audit for Class A/B manufacture; CDSCO joint-team inspection for Class C/D and, where ordered, for overseas sites on import.
8. Respond to queries and receive the licenceAnswer the deficiency letter within the stipulated period; on approval the licence issues in Form MD-5 / MD-9 (manufacture) or MD-15 (import).

💰 Government Fees

Fees are set in the Second Schedule of the Medical Devices Rules and paid online through the CDSCO portal. They differ sharply by route and class:

Import fees under Form MD-15 run from roughly USD 1,000 per site plus USD 50 per device for lower-risk devices to about USD 3,000 per site plus USD 1,500 per device for Class C and D. Always confirm the current figure on the CDSCO portal before you file, as the schedule is revised from time to time.

⏱️ Timeline & Validity at a Glance

The single biggest lever on timeline is the quality of the first submission: every deficiency letter effectively restarts the clock, so a dossier that pre-empts the common objections is worth far more than one filed quickly and corrected later. Unlike the old registration certificates, an MDR 2017 licence does not carry an expiry date — it stays valid as long as the retention fee is paid every five years and the conditions of licence are met.

⚠️ Where HIV Test Kits Applications Get Queried

Common query reasons for HIV-kit IVD applications are:

• Performance data not from a CDSCO-designated referral laboratory, or below the required sensitivity/specificity.
• Missing seroconversion-panel or reproducibility data.
• Stability data not supporting the labelled shelf-life.
• IVD labelling missing the analyte, lot or IVD symbol per ISO 18113.
• Free Sale Certificate scope not covering the exact kit on import.

🔗 Related Approvals Alongside CDSCO

A CDSCO device licence rarely travels alone. Depending on the device and the business, plan for these adjacent approvals in parallel, because any one of them can hold a consignment at the port or stop a sale even when the CDSCO licence is in order:

• Importer-Exporter Code (DGFT) — mandatory for any importer of record before the first consignment.
• Wholesale / sale licence (Form 20B / 21B, or Form MD-42) — for stocking and distributing the device in India; the Indian Authorised Agent for an import licence must already hold one.
• Legal Metrology (LMPC) registration — importers of pre-packaged devices declare MRP, net quantity, importer details and country of origin on the pack.
• BIS certification — where the device or its electrical components fall under a mandatory BIS/CRS scheme (for example many electro-medical devices).

✅ Post-Approval Obligations

The licence is the start of an ongoing compliance duty, not the end of it. After grant, the licensee must:

• Print the licence number on the label and keep the Essential Principles conformity current.
• Operate a Post-Market Surveillance (PMS) system and file the Periodic Safety Update Report (PSUR) on the schedule for the device's class.
• Report adverse events and field safety corrective actions through the Materiovigilance Programme of India (MvPI) and to CDSCO within the prescribed timelines.
• Report any change in device, materials, site, labelling or QMS, and any regulatory action or recall in another country, and act on it.
• Retain distribution records for traceability and allow CDSCO to draw samples and inspect the premises.
• Pay the retention fee every five years to keep the licence in force, and track BIS/ISO standard revisions.

❓ Frequently Asked Questions